BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 12754505)

  • 1. SOCS3 negatively regulates IL-6 signaling in vivo.
    Croker BA; Krebs DL; Zhang JG; Wormald S; Willson TA; Stanley EG; Robb L; Greenhalgh CJ; Förster I; Clausen BE; Nicola NA; Metcalf D; Hilton DJ; Roberts AW; Alexander WS
    Nat Immunol; 2003 Jun; 4(6):540-5. PubMed ID: 12754505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 regulates the plasticity of gp130 signaling.
    Lang R; Pauleau AL; Parganas E; Takahashi Y; Mages J; Ihle JN; Rutschman R; Murray PJ
    Nat Immunol; 2003 Jun; 4(6):546-50. PubMed ID: 12754506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.
    Yasukawa H; Ohishi M; Mori H; Murakami M; Chinen T; Aki D; Hanada T; Takeda K; Akira S; Hoshijima M; Hirano T; Chien KR; Yoshimura A
    Nat Immunol; 2003 Jun; 4(6):551-6. PubMed ID: 12754507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
    Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
    J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
    Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
    Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
    Song MM; Shuai K
    J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3.
    Stoiber D; Stockinger S; Steinlein P; Kovarik J; Decker T
    J Immunol; 2001 Jan; 166(1):466-72. PubMed ID: 11123325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
    Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
    J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
    Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3.
    Shen X; Hong F; Nguyen VA; Gao B
    FEBS Lett; 2000 Sep; 480(2-3):132-6. PubMed ID: 11034314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
    Cassatella MA; Gasperini S; Bovolenta C; Calzetti F; Vollebregt M; Scapini P; Marchi M; Suzuki R; Suzuki A; Yoshimura A
    Blood; 1999 Oct; 94(8):2880-9. PubMed ID: 10515892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo.
    Naka T; Tsutsui H; Fujimoto M; Kawazoe Y; Kohzaki H; Morita Y; Nakagawa R; Narazaki M; Adachi K; Yoshimoto T; Nakanishi K; Kishimoto T
    Immunity; 2001 May; 14(5):535-45. PubMed ID: 11371356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells.
    Usui E; Nishii K; Katayama N; Lorenzo V F; Chen F; Monma F; Otsuki T; Shiku H
    Hematol J; 2004; 5(6):505-12. PubMed ID: 15570293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.